Cardiac Resynchronization Therapy: An Established Pacing Therapy for Heart Failure and Mechanical Dyssynchrony

Indexed in: Scopus

In recent decades, the prevalence of heart failure has steadily increased and can be considered a contemporary cardiovascular epidemic. Therefore, treatment of heart failure is a primary focus of ...
[view complete introduction]

US $
15

*(Excluding Mailing and Handling)



Indications of Cardiac Resynchronization Therapy Based on Clinical Guidelines

Pp. 33-37 (5)

Concepción Alonso-Martin, Nuria Rivas Gandara, Oscar Alcalde Rodríguez and Angel Moya Mitjans

Abstract

Since the first application of cardiac resynchronization therapy (CRT) in 1994, an important body of information has been delivered from many randomized trials including a large number of patients. Most of these trials have showed strong evidence to support the use of CRT to improve heart failure symptoms, quality of life, left ventricular ejection fraction, exercise capacity and survival. As a result, current guidelines recommend the use of CRT as a Class I indication in patients with NYHA classes III or IV, LVEF less than 35%, QRS duration greater than120 ms, LV end-diastolic diameter > 55 mm and, sinus rhythm. However, a lack of information exists regarding other scenarios such as patients in NYHA classes II, patients with a narrow QRS complex, patients with normal ejection fraction or patients with baseline rhythms other than sinus rhythm such as those in atrial fibrillation or pacing dependent. The following chapter is dedicated to the indications for CRT therapy recommended on current clinical guidelines from the American and European Societies reviewing the clinical evidence supporting these indications.

Keywords:

Mechanical dyssynchrony, electrical dyssynchrony, heart failure, ventricular dysfunction, cardiac, resynchronization therapy

Affiliation:

Cardiology Department, Hospital Universitari de la Vall d`Hebron, Barcelona, Spain.